The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Psychological impact of genetic testing for cancer susceptibility: an update of the literature
Open accessAbstract
This article presents an overview of the rapidly evolving body of literature on the psychological impact of genetic testing for hereditary breast/ovarian cancer susceptibility, hereditary non-polyposis colorectal cancer (HNPCC) and familial adenomatous polyposis (FAP). Uptake of genetic testing for BRCA1/2 and HNPCC-related mutations is more consistently related to psychological factors, rather than sociodemographic variables. Most studies on the psychological impact of genetic testing amongst individuals who have never been affected by cancer demonstrate that non-carriers derive significant psychological benefits from genetic testing, while no adverse effects have been observed amongst carriers. These benefits are more clear-cut for HNPCC, compared to hereditary breast/ovarian cancer, reflecting differences in risk management options. The few studies available on individuals affected with cancer indicate that the impact of genetic testing is mediated and amplified by their former experience of cancer. Future directions and challenges of research in this area are reviewed. In particular, more empirical data are needed on the broader impact of genetic testing on those with inconclusive results or results of uncertain significance. As genetic testing is becoming available for other types of familial cancer, additional investigations will be needed as there is evidence to suggest that the impact of genetic testing may be unique to each type of familial cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Impact of Event Scale: A Measure of Subjective Stress
Horowitz, M., Wilner, N., & Alvarez, W. (1979) · Psychosomatic Medicine · doi:10.1097/00006842-197905000-00004 · Cited by 7,813
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
Järvinen, H. J., Aarnio, M., Mustonen, H., Aktan–Collan, K., Aaltonen, L. A., Peltomäki, P., Chapelle, A. D. L., & Mecklin, J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70168-5 · Cited by 1,337
Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation
Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., Ellis, N. A., Boyd, J., Borgen, P. I., Barakat, R. R., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020119 · Cited by 1,251
Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van ’t Veer, L., Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.188 · Cited by 1,171
Risch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Kwan, E., Jack, E., Vesprini, D. J., Kuperstein, G., Abrahamson, J. L. A., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318787 · Cited by 986
Lerman, C. (1996) · JAMA · doi:10.1001/jama.1996.03530480027036 · Cited by 792
Cancer Risks for Male Carriers of Germline Mutations in BRCA1 or BRCA2: A Review of the Literature
Liede, A., Karlan, B. Y., & Narod, S. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.055 · Cited by 407
Whittemore, A. S., Gong, G. D., & Itnyre, J. (1997) · PubMed · Cited by 383
Cited by
Information Avoidance: Who, What, When, and Why
Sweeny, K., Melnyk, D., Miller, W., & Shepperd, J. A. (2010) · Review of General Psychology · doi:10.1037/a0021288 · Cited by 634
Malkin, D. (2011) · Genes & Cancer · doi:10.1177/1947601911413466 · Cited by 508
Hollands, G. J., French, D. P., Griffin, S. J., Prevost, A. T., Sutton, S., King, S., & Marteau, T. M. (2016) · BMJ · doi:10.1136/bmj.i1102 · Cited by 483
Palomaki, G. E., McClain, M. R., Melillo, S., Hampel, H. L., & Thibodeau, S. N. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e31818fa2db · Cited by 467
Riley, B. D., Culver, J. O., Skrzynia, C., Senter, L. A., Peters, J. A., Costalas, J. W., Callif‐Daley, F., Grumet, S. C., Hunt, K. S., Nagy, R. S., et al. (2012) · Journal of Genetic Counseling · doi:10.1007/s10897-011-9462-x · Cited by 328
A systematic review of perceived risks, psychological and behavioral impacts of genetic testing
Heshka, J. T., Palleschi, C., Howley, H., Wilson, B., & Wells, P. S. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31815f524f · Cited by 328
Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours
Marteau, T. M., French, D. P., Griffin, S. J., Prevost, A. T., Sutton, S., Watkinson, C., Attwood, S., & Hollands, G. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007275.pub2 · Cited by 269
Ringwald, J., Wochnowski, C., Bosse, K., Giel, K. E., Schäffeler, N., Zipfel, S., & Teufel, M. (2016) · Journal of Genetic Counseling · doi:10.1007/s10897-016-9949-6 · Cited by 114
Implementation and utilization of genetic testing in personalized medicine
Scott, S., Abul-Husn, N., Owusu Obeng, A., Sanderson, S., & Gottesman, O. (2014) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s48887 · Cited by 106
Persky, S., Kaphingst, K. A., Condit, C. M., & McBride, C. M. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e318159a344 · Cited by 91
Vetsch, J., Wakefield, C. E., Warby, M., Tucker, K., Patterson, P., McGill, B. C., Metcalfe, A., Cohn, R. J., & Fardell, J. E. (2018) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2017.0102 · Cited by 26
Metadata
- Authors
- Meiser, B.
- Venue
- Psycho-Oncology
- Publisher
- Wiley
- Published
- 2005
- Volume
- 14
- Issue
- 12
- Pages
- 1060-1074
- ISSN
- 1057-9249 (ISSN-L)
- 1099-1611
- OpenAlex
- W2107768095
- Cited by
- 303
- References
- 72
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.